CLL, real-world evidence, acalabrutinib
Showing 1 - 25 of >10,000
Orelabrutinib in the Treatment of CLL/SLL
Not yet recruiting
- CLL/SLL
- (no location specified)
Jul 26, 2023
Aveir DR Real-World Evidence Post-Approval Study
Not yet recruiting
- Cardiac Pacemaker
- +2 more
- Aveir DR Leadless Pacemaker System
-
Sylmar, CaliforniaAbbott
Jul 5, 2023
Real-World Evidence on Cardiovascular Safety of CONTRAVE® in
Completed
- Obesity
-
Brentwood, TennesseeCurrax Pharmaceuticals
Oct 17, 2023
Heart Failure Trial (Barostim™ System)
Not yet recruiting
- Heart Failure
- Barostim™ System
- (no location specified)
May 5, 2023
Dentin Sensitivity Trial (Stannous fluoride)
Not yet recruiting
- Dentin Sensitivity
- Stannous fluoride
- (no location specified)
Sep 13, 2023
Real World Evidence on the Use of Medical Cannabis in Pediatrics
Not yet recruiting
- Cancer
- +2 more
- Medical Cannabis
- (no location specified)
May 8, 2023
Acalabrutinib in Chronic Lymphocytic Leukaemia in United Kingdom
Recruiting
- Chronic Lymphocytic Leukemia, CLL
-
Aylesbury, United Kingdom
- +7 more
Jan 12, 2023
ALICIA (Acalabrutinib in CLL Therapy)
Recruiting
- Chronic Lymphocytic Leukemia
-
Irkutsk, Russian Federation
- +12 more
Jul 27, 2022
Real-World Evidence Data Analysis of 1-year Consecutive Use of
Not yet recruiting
- Migraine
- Nerivio
- (no location specified)
Feb 26, 2023
PRostate Olaparib Real World Evidence Study
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- (no location specified)
Sep 4, 2023
Depression, Pregnancy Trial in Seoul (MINDD STIM+)
Not yet recruiting
- Depression
- Pregnancy
- MINDD STIM+
-
Seoul, Republic Of Korea, Korea, Republic ofSeoul National University Hospital
Aug 29, 2023
Adjunctive Anti-seizure Medication Real World Evidence Study
Recruiting
- Epilepsy
- ASM as adjunctive therapy
-
Milan, ItalyFondazione IRCCS Istituto Neurologico "Carlo Besta" U.O. Epilett
May 17, 2023
ABBV-951 Subcutaneous Infusion to Assess Change in Disease
Not yet recruiting
- Parkinson's Disease (PD)
- (no location specified)
Oct 25, 2023
Real-world Evidence Study on Cystistat
Not yet recruiting
- Interstitial Cystitis and Bladder Pain Syndrome
- intravesical sodium hyaluronate (Cystistat®)
- (no location specified)
Sep 13, 2022
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
Use of Cemiplimab in Adult Patients in UK
Active, not recruiting
- Cutaneous Squamous Cell Carcinoma
- No intervention
-
Reading, Berkshire, United KingdomSanofi-Aventis UK
Aug 7, 2022
Early Real-world Evidence of Brolucizumab in Neovascular
Completed
- Neurovascular Age-related Macular Degeneration
-
Bangalore, India
- +3 more
Apr 26, 2023
Common Cold Trial in Swadlincote (Otrivine Congestion Relief)
Completed
- Common Cold
- Otrivine Congestion Relief
-
Swadlincote, Derbyshire, United KingdomThe VCTC
Jan 17, 2023
Characterize REAL-WORLD EVIDENCE Regarding Safety and
Not yet recruiting
- Coronary Artery Stenosis
- (no location specified)
Sep 7, 2022
Chronic Rhinitis Trial in United States (NEUROMARK System)
Recruiting
- Chronic Rhinitis
- NEUROMARK System
-
Birmingham, Alabama
- +3 more
Jul 5, 2023
Secukinumab Effectiveness in Axial Spondyloarthritis and
Completed
- Axial Spondyloarthritis
- Psoriatic Arthritis
-
Madrid, Spain
- +2 more
Dec 22, 2022
Characterize REAL-WORLD EVIDENCE Regarding Safety and
Not yet recruiting
- Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts
- (no location specified)
Sep 7, 2022
Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS) Trial in France, United States (Sutimlimab)
Recruiting
- Cold Agglutinin Disease (CAD)
- Cold Agglutinin Syndrome (CAS)
-
Birmingham, Alabama
- +7 more
Mar 28, 2023